Combo can make tumours disappear in days

A combination of two targeted drugs can make some breast tumours disappear in less than a fortnight, delegates at a major breast cancer conference this week heard.

More than 25% of 66 women with early HER2+ breast cancer had either a pathological complete response or minimal residual disease after just 11 days on a combination of trastuzumab and lapatinib, both targeted therapies for HER2+ tumours, according to a presentation at the 10th European Breast Cancer Conference (EBCC-10).